BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 29033382)

  • 1. Clinical-pathological correlations in three patients with fibrodysplasia ossificans progressiva.
    Wentworth KL; Bigay K; Chan TV; Ho JP; Morales BM; Connor J; Brooks E; Shahriar Salamat M; Sanchez HC; Wool G; Pignolo RJ; Kaplan FS; Hsiao EC
    Bone; 2018 Apr; 109():104-110. PubMed ID: 29033382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An mTOR Signaling Modulator Suppressed Heterotopic Ossification of Fibrodysplasia Ossificans Progressiva.
    Hino K; Zhao C; Horigome K; Nishio M; Okanishi Y; Nagata S; Komura S; Yamada Y; Toguchida J; Ohta A; Ikeya M
    Stem Cell Reports; 2018 Nov; 11(5):1106-1119. PubMed ID: 30392977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of fibrodysplasia ossificans progressiva: cross-sectional analysis of annotated baseline phenotypes.
    Pignolo RJ; Baujat G; Brown MA; De Cunto C; Di Rocco M; Hsiao EC; Keen R; Al Mukaddam M; Sang KLQ; Wilson A; White B; Grogan DR; Kaplan FS
    Orphanet J Rare Dis; 2019 May; 14(1):98. PubMed ID: 31053156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic stem-cell contribution to ectopic skeletogenesis.
    Kaplan FS; Glaser DL; Shore EM; Pignolo RJ; Xu M; Zhang Y; Senitzer D; Forman SJ; Emerson SG
    J Bone Joint Surg Am; 2007 Feb; 89(2):347-57. PubMed ID: 17272450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Most Fractures Treated Nonoperatively in Individuals With Fibrodysplasia Ossificans Progressiva Heal With a Paucity of Flareups, Heterotopic Ossification, and Loss of Mobility.
    Lindborg CM; Al Mukaddam M; Baujat G; Cho TJ; De Cunto CL; Delai PLR; Eekhoff EMW; Haga N; Hsiao EC; Morhart R; de Ruiter R; Scott C; Seemann P; Szczepanek M; Tabarkiewicz J; Pignolo RJ; Kaplan FS
    Clin Orthop Relat Res; 2023 Dec; 481(12):2447-2458. PubMed ID: 37156007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrodysplasia ossificans progressiva: a current review of imaging findings.
    Bauer AH; Bonham J; Gutierrez L; Hsiao EC; Motamedi D
    Skeletal Radiol; 2018 Aug; 47(8):1043-1050. PubMed ID: 29445932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical staging of Fibrodysplasia Ossificans Progressiva (FOP).
    Pignolo RJ; Kaplan FS
    Bone; 2018 Apr; 109():111-114. PubMed ID: 28943457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palovarotene Inhibits Heterotopic Ossification and Maintains Limb Mobility and Growth in Mice With the Human ACVR1(R206H) Fibrodysplasia Ossificans Progressiva (FOP) Mutation.
    Chakkalakal SA; Uchibe K; Convente MR; Zhang D; Economides AN; Kaplan FS; Pacifici M; Iwamoto M; Shore EM
    J Bone Miner Res; 2016 Sep; 31(9):1666-75. PubMed ID: 26896819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint-specific risk of impaired function in fibrodysplasia ossificans progressiva (FOP).
    Pignolo RJ; Durbin-Johnson BP; Rocke DM; Kaplan FS
    Bone; 2018 Apr; 109():124-133. PubMed ID: 28627475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cartilage-derived retinoic acid-sensitive protein (CD-RAP): A stage-specific biomarker of heterotopic endochondral ossification (HEO) in fibrodysplasia ossificans progressiva (FOP).
    Lindborg CM; Brennan TA; Wang H; Kaplan FS; Pignolo RJ
    Bone; 2018 Apr; 109():153-157. PubMed ID: 28963080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurosurgical management of symptomatic thoracic spinal ossification in a patient with fibrodysplasia ossificans progressiva.
    Grobelny BT; Rubin D; Fleischut P; Rubens E; Mack PF; Fink M; Placantonakis DG; Elowitz EH
    J Neurosurg Spine; 2012 Mar; 16(3):285-8. PubMed ID: 22176432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clearance of Senescent Cells From Injured Muscle Abrogates Heterotopic Ossification in Mouse Models of Fibrodysplasia Ossificans Progressiva.
    Wang H; Zhang Q; Kaplan FS; Pignolo RJ
    J Bone Miner Res; 2022 Jan; 37(1):95-107. PubMed ID: 34633114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Living with Fibrodysplasia Ossificans Progressiva: Radiological Images of a Patient with Extensive Heterotopic Ossification.
    Kotb MM; Omar UF; Kaliya-Perumal AK
    Diagnostics (Basel); 2023 May; 13(10):. PubMed ID: 37238196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of osteoclasts in heterotopic ossification enhanced by fibrodysplasia ossificans progressiva-related activin-like kinase 2 mutation in mice.
    Kawao N; Yano M; Tamura Y; Okumoto K; Okada K; Kaji H
    J Bone Miner Metab; 2016 Sep; 34(5):517-25. PubMed ID: 26204847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the Identical Human Mutation in
    Casal ML; Engiles JB; Zakošek Pipan M; Berkowitz A; Porat-Mosenco Y; Mai W; Wurzburg K; Xu MQ; Allen R; ODonnell PA; Henthorn PS; Thompson K; Shore EM
    Vet Pathol; 2019 Jul; 56(4):614-618. PubMed ID: 31007133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical management of bilateral hip fractures in a patient with fibrodysplasia ossificans progressiva treated with the RAR-γ agonist palovarotene: a case report.
    Singh S; Kidane J; Wentworth KL; Motamedi D; Morshed S; Schober AE; Hsiao EC
    BMC Musculoskelet Disord; 2020 Apr; 21(1):204. PubMed ID: 32245464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrodysplasia Ossificans Progressiva: What Have We Achieved and Where Are We Now? Follow-up to the 2015 Lorentz Workshop.
    de Ruiter RD; Smilde BJ; Pals G; Bravenboer N; Knaus P; Schoenmaker T; Botman E; Sánchez-Duffhues G; Pacifici M; Pignolo RJ; Shore EM; van Egmond M; Van Oosterwyck H; Kaplan FS; Hsiao EC; Yu PB; Bocciardi R; De Cunto CL; Longo Ribeiro Delai P; de Vries TJ; Hilderbrandt S; Jaspers RT; Keen R; Koolwijk P; Morhart R; Netelenbos JC; Rustemeyer T; Scott C; Stockklausner C; Ten Dijke P; Triffit J; Ventura F; Ravazzolo R; Micha D; Eekhoff EMW
    Front Endocrinol (Lausanne); 2021; 12():732728. PubMed ID: 34858325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrodysplasia ossificans progressiva (stone man syndrome): a case report.
    Shah ZA; Rausch S; Arif U; El Yafawi B
    J Med Case Rep; 2019 Dec; 13(1):364. PubMed ID: 31785620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of fibrodysplasia ossificans progressiva (FOP) in the United States: estimate from three treatment centers and a patient organization.
    Pignolo RJ; Hsiao EC; Baujat G; Lapidus D; Sherman A; Kaplan FS
    Orphanet J Rare Dis; 2021 Aug; 16(1):350. PubMed ID: 34353327
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.